Zyversa Therapeutics Inc
(ZVSA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 09-2021 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 329 | N/A |
| Other current assets | 483 | 0 |
| TOTAL | $812 | $N/A |
| Non-Current Assets | ||
| Other Non-Current Assets | 287 | 0 |
| TOTAL | $287 | $N/A |
| Total Assets | $1,126 | $N/A |
| Liabilities | ||
| Current Liabilities | ||
| Accounts payable and accrued liabilities | 2,000 | 0 |
| Accrued Expenses | 1,914 | N/A |
| Other current liabilities | 561 | N/A |
| TOTAL | $13,626 | $N/A |
| Non-Current Liabilities | ||
| Other Non-Current Liabilities | 331 | 0 |
| TOTAL | $331 | $N/A |
| Total Liabilities | $13,958 | $N/A |
| Shareholders' Equity | ||
| Shares Outstanding, K | N/A | 28 |
| Retained earnings | -52,897 | N/A |
| Other shareholders' equity | 1 | 0 |
| TOTAL | $-12,831 | $N/A |
| Total Liabilities And Equity | $1,127 | $0 |